This specialized lyophilized blend combines four of the most highly researched peptides in regenerative science: BPC-157 (10mg), TB-500 (10mg), KPV (10mg), and GHK-Cu (50mg)
Clinical approach considerations: Patient selection: Stable post-surgical patients with inadequate weight loss, weight regain, or persistent metabolic disease Timing: Individualized based on weight trajectory and metabolic status, often when weight loss plateaus or regain is documented Baseline evaluation: Comprehensive metabolic panel, nutritional markers (vitamin B12, iron studies, vitamin D, calcium, albumin), HbA1c if diabetic, lipid panel, assessment of gastrointestinal symptoms, renal function Dosing strategy: For Wegovy, initiate at 0.25 mg weekly with gradual titration (0.250.51.01.72.4 mg)
longer (8mm-12mm) may be required for intramuscular insulin delivery
Proper storage will preserve potency and effectiveness for up to 24 months from the manufacturing date